Monitoring therapy with

Deferoxamine interferes with photometric measurements of iron and UIBC, an important consideration if serum iron and UIBC measurements are used to monitor therapy with deferoxamine. Deferoxamine has a short tm ( lh) therefore, a delay of at least 4h after deferoxamine administration would be appropriate before measurements of serum iron and UIBC are repeated. 

Fig. 4 Pharmacist assessment and monitoring therapy with health status assessment information included into typical paradigm.

---